(Q27853026)

Revision as of 02:08, 30 January 2017 by Edoderoobot (talk | contribs) (‎Updated Item: Publication title set from URL of pubmedID)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

English

Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.

scientific article

Targeting TBK1 Inhibits Migration and Resistance to MEK Inhibitors in Mutant NRAS Melanoma

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

PubMed publication ID

24962318

retrieved

13 November 2016

title

Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma. (English)

1 reference

stated in

PubMed

PubMed publication ID

13 November 2016

Ha Linh Vu

0 references

Andrew E Aplin

series ordinal

0 references

publication date

October 2014

0 references

published in

Molecular Cancer Research

0 references

volume

0 references

issue

0 references

page(s)

1509-19

0 references

cites work

Structural Insights into the Functions of TBK1 in Innate Antimicrobial Immunity

1 reference

stated in

PubMed Central

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

1 reference

stated in

PubMed Central

A landscape of driver mutations in melanoma

1 reference

stated in

PubMed Central

Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases

1 reference

stated in

PubMed Central

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

stated in

PubMed Central

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

1 reference

stated in

PubMed Central

Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates

1 reference

stated in

PubMed Central

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers

1 reference

stated in

PubMed Central

Targeting RAS signalling pathways in cancer therapy

1 reference

stated in

PubMed Central

IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2

1 reference

stated in

PubMed Central

Inhibition of TBK1 attenuates radiation-induced epithelial-mesenchymal transition of A549 human lung cancer cells via activation of GSK-3β and repression of ZEB1

1 reference

stated in

PubMed Central

Alteration of cellular behavior and response to PI3K pathway inhibition by culture in 3D collagen gels

1 reference

stated in

PubMed Central

Identifiers

DOI

10.1158/1541-7786.MCR-14-0204

1 reference

stated in

PubMed

PubMed publication ID

24962318

retrieved

13 November 2016

OpenCitations bibliographic resource ID

1 reference

1 reference

PubMed publication ID

24962318

retrieved

13 November 2016

PubMed publication ID

24962318

1 reference

stated in

PubMed

PubMed publication ID

24962318

retrieved

13 November 2016

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853026&oldid=439051144"